Dynagrow Capital
VC Fund
Dynagrow Capital is an investment firm and is an affiliate of Caret Group president Fred Hassan.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Dynagrow Capital invests in
Stages Dynagrow Capital invests in
Countries Dynagrow Capital invests in
Investment Focus
Industry
- Therapeutics 2 (100%)
- Biotechnology 2 (100%)
- Health Care 1 (50%)
- Pharmaceutical 1 (50%)
- Clinical Trials 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $9.5M / Series B / Sep 30, 2026 | ||
| Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders. The company specializes in molecular machines that turn energy into mechanical work inside cells, enabling doctors to treat various disease states, including cancer, and focuses on developing innovative drugs that target cellularmotor proteins. | $3M / Seed / Feb 26, 2025 |
Co-Investors
DeepWork Capital
2 deals together
Angel Star Ventures
1 deal together
Florida Opportunity Fund
1 deal together
Mayo Clinic Ventures
1 deal together
MintPharma Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Dynagrow Capital invest in?
Dynagrow Capital invests primarily in Therapeutics, Biotechnology and Health Care startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dynagrow Capital last invest?
The most recent investment recorded for Dynagrow Capital closed in Sep 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
